RXRX Stock Analysis: Buy, Sell, or Hold?
RXRX - Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.50
0.16 (4.79%)
▲
5d:
+10.76%
30d:
+16.28%
90d:
+12.54%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 7, 2026 at $3.22 · last confirmed Aug 21, 2026
Strength: 10.0/10
Get Alerted When RXRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RXRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RXRX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: RXRX is currently trading at $3.50, which is considered extended relative to its 30-day fair value range of $3.00 to $3.33.
Technical Outlook: Technically, RXRX is in a uptrend. Immediate support is located at $2.92, while resistance sits at $3.63. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: RXRX scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.25 (+133.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RXRX is in a uptrend. Immediate support is located at $2.92, while resistance sits at $3.63. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: RXRX scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.25 (+133.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.00 -
$3.33
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
Protect Your Profits
Holding RXRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.1% above its trading range)
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.8%)
- BULLISH: Trading 133.1% below Wall St target ($7.25)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.00 -
$3.33
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.92
Resistance Level
$3.63
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.52
Wall Street Target
$7.25
(+133.1%)
Revenue Growth (YoY)
-60.1%
Share & Embed Analysis
Last updated: August 23, 2026 6:31 AM ET
Data refreshes hourly during market hours. Next update: 7:31 AM
Data refreshes hourly during market hours. Next update: 7:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RXRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Blake Borgeson
SELL
30000 shares
2026-04-07
Ben R Taylor
SELL
7956 shares
2026-03-17
Najat Khan
SELL
28298 shares
2026-03-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 40 SELL |
Advanced RXRX Option Strategies
Professional options setups generated by AI based on today's RXRX price and gamma walls.
